Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
6'-Sialyllactose (6SL) displays a wide range of the bioactive benefits, such as anti-proliferative and anti-angiogenic activities. However, the therapeutic effects of 6SL on benign prostatic hyperplasia (BPH) remain unknown.
Pubmed ID: 31547405
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Cell line BPH-1 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentions